Dinesh M. Kumar - 08 Nov 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Officer
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
08 Nov 2024
Transactions value $
$0
Form type
4
Filing time
12 Nov 2024, 16:39:25 UTC
Previous filing
05 Aug 2024
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Award $0 +67,238 +44.94% $0 216,839 08 Nov 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest subject to the achievement of certain performance goals, provided the Reporting Person is still employed with the Issuer on the date of vesting.
F2 Includes 214,370 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025 (ii) 9,790 shares, which will vest in three equal semi-annual installments beginning on January 1, 2025; and (iii) grants of 16,316, 16,316, 13,053, 6,527 and 67,238 shares, each of which will vest subject to the achievement of certain performance goals.

Remarks:

Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., a wholly owned subsidiary of Astrana Health, Inc.